Back to results
US 2014/0213644 A1Published application
Formulations and Methods for Prevention and Treatment of Oral Allergy Syndrome
OwnerZiv Harish, Russ Weinzimmerinventors
Life of this patent
Estimating the term…
Abstract
A method and formulation for the prevention and treatment for Oral Allergy Syndrome (OAS), also referred to as Pollen-associated Food Allergy Syndrome (PFAS), is disclosed. The formulation significantly reduces or prevents symptoms related to Oral Allergy Syndrome while having a superb safety record. It can significantly improve Quality of Life for millions of patients afflicted with OAS.
Claims20
A pharmaceutical formulation for use in the prevention and/or treatment of oral allergy syndrome, the formulation comprising:
- a solution of Cromolyn sodium in water at a concentration greater than 100 mg Cromolyn sodium per 5 ml water, to be applied as an oral rinse.
A method for the prevention and/or treatment of Oral Allergy Syndrome, the method comprising:
- taking into the mouth a quantity of an aqueous solution at a concentration of a range from 100 mg Cromolyn sodium per 5 ml water to 250 mg Cromolyn sodium per 5 ml water;
- swishing the solution around in the mouth for about two to ten seconds;
- and
- expectorating the solution.
1 more element
Dependencies are inferred from the claim text.